Global Live Vaccines Market Growth 2025-2031

December 2025 | 101 pages | ID: G73B9FDE0A5EN
LP Information

Abstracts

The global Live Vaccines market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LP Information, Inc. (LPI) ' newest research report, the “Live Vaccines Industry Forecast” looks at past sales and reviews total world Live Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Live Vaccines sales for 2025 through 2031. With Live Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Live Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Live Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Monovalent Live Vaccines
• Multivalent Live Vaccines

Segmentation by Application:

• Adults
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Merck
• GlaxoSmithKline
• Pfizer
• Novartis
• Astellas Pharma
• Emergent BioSolutions
• AstraZeneca

Key Questions Addressed in this Report

What is the 10-year outlook for the global Live Vaccines market?

What factors are driving Live Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Live Vaccines market opportunities vary by end market size?

How does Live Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Live Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Live Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Live Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Live Vaccines Segment by Type
  2.2.1 Monovalent Live Vaccines
  2.2.2 Multivalent Live Vaccines
2.3 Live Vaccines Sales by Type
  2.3.1 Global Live Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Live Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Live Vaccines Sale Price by Type (2020-2025)
2.4 Live Vaccines Segment by Application
  2.4.1 Adults
  2.4.2 Children
2.5 Live Vaccines Sales by Application
  2.5.1 Global Live Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Live Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Live Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Live Vaccines Breakdown Data by Company
  3.1.1 Global Live Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Live Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Live Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Live Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Live Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Live Vaccines Sale Price by Company
3.4 Key Manufacturers Live Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Live Vaccines Product Location Distribution
  3.4.2 Players Live Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LIVE VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Live Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Live Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Live Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Live Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Live Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Live Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Live Vaccines Sales Growth
4.4 APAC Live Vaccines Sales Growth
4.5 Europe Live Vaccines Sales Growth
4.6 Middle East & Africa Live Vaccines Sales Growth

5 AMERICAS

5.1 Americas Live Vaccines Sales by Country
  5.1.1 Americas Live Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Live Vaccines Revenue by Country (2020-2025)
5.2 Americas Live Vaccines Sales by Type (2020-2025)
5.3 Americas Live Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Live Vaccines Sales by Region
  6.1.1 APAC Live Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Live Vaccines Revenue by Region (2020-2025)
6.2 APAC Live Vaccines Sales by Type (2020-2025)
6.3 APAC Live Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Live Vaccines by Country
  7.1.1 Europe Live Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Live Vaccines Revenue by Country (2020-2025)
7.2 Europe Live Vaccines Sales by Type (2020-2025)
7.3 Europe Live Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Live Vaccines by Country
  8.1.1 Middle East & Africa Live Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Live Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Live Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Live Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Vaccines
10.3 Manufacturing Process Analysis of Live Vaccines
10.4 Industry Chain Structure of Live Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Live Vaccines Distributors
11.3 Live Vaccines Customer

12 WORLD FORECAST REVIEW FOR LIVE VACCINES BY GEOGRAPHIC REGION

12.1 Global Live Vaccines Market Size Forecast by Region
  12.1.1 Global Live Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Live Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Live Vaccines Forecast by Type (2026-2031)
12.7 Global Live Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Live Vaccines Product Portfolios and Specifications
  13.1.3 Merck Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Information
  13.2.2 GlaxoSmithKline Live Vaccines Product Portfolios and Specifications
  13.2.3 GlaxoSmithKline Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 GlaxoSmithKline Main Business Overview
  13.2.5 GlaxoSmithKline Latest Developments
13.3 Pfizer
  13.3.1 Pfizer Company Information
  13.3.2 Pfizer Live Vaccines Product Portfolios and Specifications
  13.3.3 Pfizer Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Pfizer Main Business Overview
  13.3.5 Pfizer Latest Developments
13.4 Novartis
  13.4.1 Novartis Company Information
  13.4.2 Novartis Live Vaccines Product Portfolios and Specifications
  13.4.3 Novartis Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Novartis Main Business Overview
  13.4.5 Novartis Latest Developments
13.5 Astellas Pharma
  13.5.1 Astellas Pharma Company Information
  13.5.2 Astellas Pharma Live Vaccines Product Portfolios and Specifications
  13.5.3 Astellas Pharma Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Astellas Pharma Main Business Overview
  13.5.5 Astellas Pharma Latest Developments
13.6 Emergent BioSolutions
  13.6.1 Emergent BioSolutions Company Information
  13.6.2 Emergent BioSolutions Live Vaccines Product Portfolios and Specifications
  13.6.3 Emergent BioSolutions Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Emergent BioSolutions Main Business Overview
  13.6.5 Emergent BioSolutions Latest Developments
13.7 AstraZeneca
  13.7.1 AstraZeneca Company Information
  13.7.2 AstraZeneca Live Vaccines Product Portfolios and Specifications
  13.7.3 AstraZeneca Live Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 AstraZeneca Main Business Overview
  13.7.5 AstraZeneca Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Live Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Live Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Monovalent Live Vaccines
Table 4. Major Players of Multivalent Live Vaccines
Table 5. Global Live Vaccines Sales by Type (2020-2025) & (K Doses)
Table 6. Global Live Vaccines Sales Market Share by Type (2020-2025)
Table 7. Global Live Vaccines Revenue by Type (2020-2025) & ($ million)
Table 8. Global Live Vaccines Revenue Market Share by Type (2020-2025)
Table 9. Global Live Vaccines Sale Price by Type (2020-2025) & (USD/Dose)
Table 10. Global Live Vaccines Sale by Application (2020-2025) & (K Doses)
Table 11. Global Live Vaccines Sale Market Share by Application (2020-2025)
Table 12. Global Live Vaccines Revenue by Application (2020-2025) & ($ million)
Table 13. Global Live Vaccines Revenue Market Share by Application (2020-2025)
Table 14. Global Live Vaccines Sale Price by Application (2020-2025) & (USD/Dose)
Table 15. Global Live Vaccines Sales by Company (2020-2025) & (K Doses)
Table 16. Global Live Vaccines Sales Market Share by Company (2020-2025)
Table 17. Global Live Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Live Vaccines Revenue Market Share by Company (2020-2025)
Table 19. Global Live Vaccines Sale Price by Company (2020-2025) & (USD/Dose)
Table 20. Key Manufacturers Live Vaccines Producing Area Distribution and Sales Area
Table 21. Players Live Vaccines Products Offered
Table 22. Live Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 26. Global Live Vaccines Sales Market Share Geographic Region (2020-2025)
Table 27. Global Live Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Live Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Live Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 30. Global Live Vaccines Sales Market Share by Country/Region (2020-2025)
Table 31. Global Live Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Live Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Live Vaccines Sales by Country (2020-2025) & (K Doses)
Table 34. Americas Live Vaccines Sales Market Share by Country (2020-2025)
Table 35. Americas Live Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Live Vaccines Sales by Type (2020-2025) & (K Doses)
Table 37. Americas Live Vaccines Sales by Application (2020-2025) & (K Doses)
Table 38. APAC Live Vaccines Sales by Region (2020-2025) & (K Doses)
Table 39. APAC Live Vaccines Sales Market Share by Region (2020-2025)
Table 40. APAC Live Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Live Vaccines Sales by Type (2020-2025) & (K Doses)
Table 42. APAC Live Vaccines Sales by Application (2020-2025) & (K Doses)
Table 43. Europe Live Vaccines Sales by Country (2020-2025) & (K Doses)
Table 44. Europe Live Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Live Vaccines Sales by Type (2020-2025) & (K Doses)
Table 46. Europe Live Vaccines Sales by Application (2020-2025) & (K Doses)
Table 47. Middle East & Africa Live Vaccines Sales by Country (2020-2025) & (K Doses)
Table 48. Middle East & Africa Live Vaccines Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Live Vaccines Sales by Type (2020-2025) & (K Doses)
Table 50. Middle East & Africa Live Vaccines Sales by Application (2020-2025) & (K Doses)
Table 51. Key Market Drivers & Growth Opportunities of Live Vaccines
Table 52. Key Market Challenges & Risks of Live Vaccines
Table 53. Key Industry Trends of Live Vaccines
Table 54. Live Vaccines Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Vaccines Distributors List
Table 57. Live Vaccines Customer List
Table 58. Global Live Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 59. Global Live Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Live Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 61. Americas Live Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Live Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 63. APAC Live Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Live Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 65. Europe Live Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Live Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 67. Middle East & Africa Live Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Live Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 69. Global Live Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Live Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 71. Global Live Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Live Vaccines Product Portfolios and Specifications
Table 74. Merck Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77. GlaxoSmithKline Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 78. GlaxoSmithKline Live Vaccines Product Portfolios and Specifications
Table 79. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 80. GlaxoSmithKline Main Business
Table 81. GlaxoSmithKline Latest Developments
Table 82. Pfizer Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Live Vaccines Product Portfolios and Specifications
Table 84. Pfizer Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Novartis Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Live Vaccines Product Portfolios and Specifications
Table 89. Novartis Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Astellas Pharma Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 93. Astellas Pharma Live Vaccines Product Portfolios and Specifications
Table 94. Astellas Pharma Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 95. Astellas Pharma Main Business
Table 96. Astellas Pharma Latest Developments
Table 97. Emergent BioSolutions Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 98. Emergent BioSolutions Live Vaccines Product Portfolios and Specifications
Table 99. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 100. Emergent BioSolutions Main Business
Table 101. Emergent BioSolutions Latest Developments
Table 102. AstraZeneca Basic Information, Live Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Live Vaccines Product Portfolios and Specifications
Table 104. AstraZeneca Live Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Live Vaccines
Figure 2. Live Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Live Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Live Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Live Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Live Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Monovalent Live Vaccines
Figure 12. Product Picture of Multivalent Live Vaccines
Figure 13. Global Live Vaccines Sales Market Share by Type in 2025
Figure 14. Global Live Vaccines Revenue Market Share by Type (2020-2025)
Figure 15. Live Vaccines Consumed in Adults
Figure 16. Global Live Vaccines Market: Adults (2020-2025) & (K Doses)
Figure 17. Live Vaccines Consumed in Children
Figure 18. Global Live Vaccines Market: Children (2020-2025) & (K Doses)
Figure 19. Global Live Vaccines Sale Market Share by Application (2024)
Figure 20. Global Live Vaccines Revenue Market Share by Application in 2025
Figure 21. Live Vaccines Sales by Company in 2025 (K Doses)
Figure 22. Global Live Vaccines Sales Market Share by Company in 2025
Figure 23. Live Vaccines Revenue by Company in 2025 ($ millions)
Figure 24. Global Live Vaccines Revenue Market Share by Company in 2025
Figure 25. Global Live Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Live Vaccines Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Live Vaccines Sales 2020-2025 (K Doses)
Figure 28. Americas Live Vaccines Revenue 2020-2025 ($ millions)
Figure 29. APAC Live Vaccines Sales 2020-2025 (K Doses)
Figure 30. APAC Live Vaccines Revenue 2020-2025 ($ millions)
Figure 31. Europe Live Vaccines Sales 2020-2025 (K Doses)
Figure 32. Europe Live Vaccines Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Live Vaccines Sales 2020-2025 (K Doses)
Figure 34. Middle East & Africa Live Vaccines Revenue 2020-2025 ($ millions)
Figure 35. Americas Live Vaccines Sales Market Share by Country in 2025
Figure 36. Americas Live Vaccines Revenue Market Share by Country (2020-2025)
Figure 37. Americas Live Vaccines Sales Market Share by Type (2020-2025)
Figure 38. Americas Live Vaccines Sales Market Share by Application (2020-2025)
Figure 39. United States Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Live Vaccines Sales Market Share by Region in 2025
Figure 44. APAC Live Vaccines Revenue Market Share by Region (2020-2025)
Figure 45. APAC Live Vaccines Sales Market Share by Type (2020-2025)
Figure 46. APAC Live Vaccines Sales Market Share by Application (2020-2025)
Figure 47. China Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. India Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Live Vaccines Sales Market Share by Country in 2025
Figure 55. Europe Live Vaccines Revenue Market Share by Country (2020-2025)
Figure 56. Europe Live Vaccines Sales Market Share by Type (2020-2025)
Figure 57. Europe Live Vaccines Sales Market Share by Application (2020-2025)
Figure 58. Germany Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. France Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Live Vaccines Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Live Vaccines Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Live Vaccines Sales Market Share by Application (2020-2025)
Figure 66. Egypt Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Live Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Live Vaccines in 2025
Figure 72. Manufacturing Process Analysis of Live Vaccines
Figure 73. Industry Chain Structure of Live Vaccines
Figure 74. Channels of Distribution
Figure 75. Global Live Vaccines Sales Market Forecast by Region (2026-2031)
Figure 76. Global Live Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Live Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Live Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Live Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Live Vaccines Revenue Market Share Forecast by Application (2026-2031)